Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Crisafulli

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Clinical and Experimental Rheumatology|January 27, 2022
Retention rate of IL-1 inhibitors in Schnitzler's syndromeFrancesca Crisafulli, Antonio Vitale, Paolo Airò, et al.
Arthritis Care & Research|July 24, 2020
Impact of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Multicenter Cohort Study of 133 Women With Undifferentiated Connective Tissue DiseaseMassimo Radin, Karen Schreiber, Irene Cecchi, et al.
Rheumatology (Oxford, England)|January 17, 2020
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolutionMassimo Radin, Karen Schreiber, Irene Cecchi, et al.
Orphanet Journal of Rare Diseases|March 11, 2026
Identifying quality of life domains and facets affected in relapsing polychondritis: a qualitative analysis for the development of a disease-specific health-related quality of life instrumentPhilippe Mertz, Oliver Sander, Raquel Faria, et al.
Seminars in Arthritis and Rheumatism|April 2, 2020
Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational studySule Yavuz, Dondu U Cansu, Dionysis Nikolopoulos, et al.
Orphanet Journal of Rare Diseases|May 15, 2025
European Reference Network (ERN) ReCONNET methodology for the cross-cultural adaptation of instruments for research and care in the context of rare connective tissue diseases (CROSSADAPT)Laurent Arnaud, Oliver Sander, Simona Rednic, et al.
Lupus Science & Medicine|June 14, 2022
Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre studyChiara Tani, Dina Zucchi, Isabell Haase, et al.
Frontiers in Immunology|November 12, 2020
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid SyndromeMaria Orietta Borghi, Asmaa Beltagy, Emirena Garrafa, et al.
Medrxiv : the Preprint Server for Health Sciences|June 27, 2020
Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndromeMaria Orietta Borghi, Asmaa Beltagy, Emirena Garrafa, et al.
Rheumatology (Oxford, England)|July 1, 2026
Development and validation of a Relapsing Polychondritis disease-specific Quality of Life instrument (ERN ReCONNET RP-QoL)Laurent Arnaud, Oliver Sander, Laura Damian, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Clinical and Experimental Rheumatology|January 27, 2022
Retention rate of IL-1 inhibitors in Schnitzler's syndromeFrancesca Crisafulli, Antonio Vitale, Paolo Airò, et al.
Arthritis Care & Research|July 24, 2020
Impact of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Multicenter Cohort Study of 133 Women With Undifferentiated Connective Tissue DiseaseMassimo Radin, Karen Schreiber, Irene Cecchi, et al.
Rheumatology (Oxford, England)|January 17, 2020
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolutionMassimo Radin, Karen Schreiber, Irene Cecchi, et al.
Orphanet Journal of Rare Diseases|March 11, 2026
Identifying quality of life domains and facets affected in relapsing polychondritis: a qualitative analysis for the development of a disease-specific health-related quality of life instrumentPhilippe Mertz, Oliver Sander, Raquel Faria, et al.
Seminars in Arthritis and Rheumatism|April 2, 2020
Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational studySule Yavuz, Dondu U Cansu, Dionysis Nikolopoulos, et al.
Orphanet Journal of Rare Diseases|May 15, 2025
European Reference Network (ERN) ReCONNET methodology for the cross-cultural adaptation of instruments for research and care in the context of rare connective tissue diseases (CROSSADAPT)Laurent Arnaud, Oliver Sander, Simona Rednic, et al.
Lupus Science & Medicine|June 14, 2022
Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre studyChiara Tani, Dina Zucchi, Isabell Haase, et al.
Frontiers in Immunology|November 12, 2020
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid SyndromeMaria Orietta Borghi, Asmaa Beltagy, Emirena Garrafa, et al.
Medrxiv : the Preprint Server for Health Sciences|June 27, 2020
Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndromeMaria Orietta Borghi, Asmaa Beltagy, Emirena Garrafa, et al.
Rheumatology (Oxford, England)|July 1, 2026
Development and validation of a Relapsing Polychondritis disease-specific Quality of Life instrument (ERN ReCONNET RP-QoL)Laurent Arnaud, Oliver Sander, Laura Damian, et al.
Pageof 6